ERK/MAPK signaling and autism spectrum disorders.

The MAPK pathway is a prominent intracellular signaling pathway regulating various intracellular functions. Components of this pathway are mutated in a related collection of congenital syndromes collectively referred to as neuro-cardio-facio-cutaneous syndromes (NCFC) or Rasopathies. Recently, it has been appreciated that these disorders are associated with autism spectrum disorders (ASD). In addition, idiopathic ASD has also implicated the MAPK signaling cascade as a common pathway that is affected by many of the genetic variants that have been found to be linked to ASDs. This chapter describes the components of the MAPK pathway and how it is regulated. Furthermore, this chapter will highlight the various functions of the MAPK pathway during both embryonic development of the central nervous system (CNS) and its roles in neuronal physiology and ultimately, behavior. Finally, we will summarize the perturbations to MAPK signaling in various models of autism spectrum disorders and Rasopathies to highlight how dysregulation of this pivotal pathway may contribute to the pathogenesis of autism.

[1]  D. Teis,et al.  Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction. , 2002, Developmental cell.

[2]  W. Berger,et al.  Vaults and the major vault protein: Novel roles in signal pathway regulation and immunity , 2008, Cellular and Molecular Life Sciences.

[3]  M. Bear,et al.  Chemical induction of mGluR5- and protein synthesis--dependent long-term depression in hippocampal area CA1. , 2001, Journal of neurophysiology.

[4]  Joel M Stein,et al.  Histone Deacetylase Inhibitors Enhance Memory and Synaptic Plasticity via CREB: CBP-Dependent Transcriptional Activation , 2007, The Journal of Neuroscience.

[5]  R. Dolmetsch,et al.  16p11.2 Deletion Syndrome Mice Display Sensory and Ultrasonic Vocalization Deficits During Social Interactions , 2015, Autism research : official journal of the International Society for Autism Research.

[6]  E. Kandel,et al.  Rap1 Couples cAMP Signaling to a Distinct Pool of p42/44MAPK Regulating Excitability, Synaptic Plasticity, Learning, and Memory , 2003, Neuron.

[7]  H. Zoghbi,et al.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.

[8]  C. Lange-Carter,et al.  A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf , 1993, Science.

[9]  R. Roskoski ERK1/2 MAP kinases: structure, function, and regulation. , 2012, Pharmacological research.

[10]  V. Douet,et al.  Hippocampus/amygdala alterations, loss of heparan sulfates, fractones and ventricle wall reduction in adult BTBR T+ tf/J mice, animal model for autism , 2012, Neuroscience Letters.

[11]  M. Weber,et al.  Tyrosine phosphorylation of specific proteins after mitogen stimulation of chicken embryo fibroblasts , 1983, Molecular and cellular biology.

[12]  F. Wright,et al.  Large-Scale Gene Expression Differences Across Brain Regions and Inbred Strains Correlate With a Behavioral Phenotype , 2006, Genetics.

[13]  Alcino J. Silva,et al.  Effect of Simvastatin on Cognitive Functioning in Children with Neurofibromatosis Type 1 a Randomized Controlled Trial , 2022 .

[14]  V. Broccoli,et al.  Tbr2-positive intermediate (basal) neuronal progenitors safeguard cerebral cortex expansion by controlling amplification of pallial glutamatergic neurons and attraction of subpallial GABAergic interneurons. , 2010, Genes & development.

[15]  Jill L Silverman,et al.  Modeling fragile X syndrome in the Fmr1 knockout mouse. , 2014, Intractable & rare diseases research.

[16]  H. Rubinfeld,et al.  The ERK cascade , 2005, Molecular biotechnology.

[17]  David Lodge,et al.  DHPG-induced LTD in area CA1 of juvenile rat hippocampus; characterisation and sensitivity to novel mGlu receptor antagonists , 1999, Neuropharmacology.

[18]  E. Kandel,et al.  Brief theta-burst stimulation induces a transcription-dependent late phase of LTP requiring cAMP in area CA1 of the mouse hippocampus. , 1997, Learning & memory.

[19]  G. Ratto,et al.  A Kinase with a Vision , 2006 .

[20]  L. Cantley,et al.  Paxillin serves as an ERK-regulated scaffold for coordinating FAK and Rac activation in epithelial morphogenesis. , 2004, Molecular cell.

[21]  C. Marshall,et al.  Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[22]  J. Schlessinger,et al.  Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.

[23]  N. Sonenberg,et al.  Regulation of Eukaryotic Initiation Factor 4E by Converging Signaling Pathways during Metabotropic Glutamate Receptor-Dependent Long-Term Depression , 2006, The Journal of Neuroscience.

[24]  R. Nadeau,et al.  Sef Inhibits Fibroblast Growth Factor Signaling by Inhibiting FGFR1 Tyrosine Phosphorylation and Subsequent ERK Activation* , 2003, The Journal of Biological Chemistry.

[25]  M. Besson,et al.  Involvement of the Extracellular Signal-Regulated Kinase Cascade for Cocaine-Rewarding Properties , 2000, The Journal of Neuroscience.

[26]  F. Volkmar,et al.  Autistic behaviors in a boy with noonan syndrome , 1983, Journal of autism and developmental disorders.

[27]  E. Zackai,et al.  Aortic root dilation in patients with 22q11.2 deletion syndrome , 2009, American journal of medical genetics. Part A.

[28]  G. Rubin,et al.  KSR modulates signal propagation within the MAPK cascade. , 1996, Genes & development.

[29]  S. Kushner,et al.  Mechanisms underlying cognitive deficits in a mouse model for Costello Syndrome are distinct from other RASopathy mouse models , 2017, Scientific Reports.

[30]  Y. Matsubara,et al.  Adult mice expressing a Braf Q241R mutation on an ICR/CD-1 background exhibit a cardio-facio-cutaneous syndrome phenotype. , 2015, Human molecular genetics.

[31]  Armin Schumacher,et al.  The Nuclear Kinase Mitogen- and Stress-Activated Protein Kinase 1 Regulates Hippocampal Chromatin Remodeling in Memory Formation , 2007, The Journal of Neuroscience.

[32]  S. Saitta,et al.  MAP'ing CNS Development and Cognition: An ERKsome Process , 2009, Neuron.

[33]  M. Bear,et al.  Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression. , 2000, Science.

[34]  G. Banker,et al.  Neuronal Calcium Activates a Rap1 and B-Raf Signaling Pathway via the Cyclic Adenosine Monophosphate-dependent Protein Kinase* , 2000, The Journal of Biological Chemistry.

[35]  W. Kolch Coordinating ERK/MAPK signalling through scaffolds and inhibitors , 2005, Nature Reviews Molecular Cell Biology.

[36]  D. Alessi,et al.  Mitogen‐ and stress‐activated protein kinase‐1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB , 1998, The EMBO journal.

[37]  H. Schaeffer,et al.  MEK partner 1 (MP1): Regulation of oligomerization in MAP kinase signaling , 2005, Journal of cellular biochemistry.

[38]  J. Pouysségur,et al.  Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. , 2002, European journal of biochemistry.

[39]  Catherine A. Sugar,et al.  A randomized placebo‐controlled lovastatin trial for neurobehavioral function in neurofibromatosis I , 2016, Annals of clinical and translational neurology.

[40]  Yasushi Kobayashi,et al.  ERK2 Contributes to the Control of Social Behaviors in Mice , 2011, The Journal of Neuroscience.

[41]  É. Khandjian,et al.  A Novel Function for Fragile X Mental Retardation Protein in Translational Activation , 2009, PLoS biology.

[42]  K. Rauen,et al.  Mutational and functional analysis in human Ras/MAP kinase genetic syndromes. , 2010, Methods in molecular biology.

[43]  E. Nishida,et al.  Dynamics of the Ras/ERK MAPK Cascade as Monitored by Fluorescent Probes* , 2006, Journal of Biological Chemistry.

[44]  J. Schlessinger,et al.  Demonstration of epidermal growth factor-induced receptor dimerization in living cells using a chemical covalent cross-linking agent. , 1988, The Journal of biological chemistry.

[45]  Yasushi Kobayashi,et al.  Deletion of ERK1 and ERK2 in the CNS Causes Cortical Abnormalities and Neonatal Lethality: Erk1 Deficiency Enhances the Impairment of Neurogenesis in Erk2-Deficient Mice , 2011, The Journal of Neuroscience.

[46]  J. Kohyama,et al.  Neuronal differentiation of neural precursor cells is promoted by the methyl-CpG-binding protein MeCP2 , 2009, Experimental Neurology.

[47]  L Bibbs,et al.  A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. , 1994, Science.

[48]  Scott T. Wong,et al.  Cross Talk between ERK and PKA Is Required for Ca2+ Stimulation of CREB-Dependent Transcription and ERK Nuclear Translocation , 1998, Neuron.

[49]  Martin Zenker,et al.  Clinical manifestations of mutations in RAS and related intracellular signal transduction factors , 2011, Current opinion in pediatrics.

[50]  Satoko Nishimoto,et al.  MAPK signalling: ERK5 versus ERK1/2 , 2006, EMBO reports.

[51]  Michael E. Ragozzino,et al.  Differences in BTBR T+ tf/J and C57BL/6J mice on probabilistic reversal learning and stereotyped behaviors , 2012, Behavioural Brain Research.

[52]  R. Baron,et al.  Spred is a Sprouty-related suppressor of Ras signalling , 2001, Nature.

[53]  V. Caviness,et al.  The cell cycle of the pseudostratified ventricular epithelium of the embryonic murine cerebral wall , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[54]  W. Brown,et al.  Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment , 2017, Pediatrics.

[55]  R. Huganir,et al.  SynGAP: a Synaptic RasGAP that Associates with the PSD-95/SAP90 Protein Family , 1998, Neuron.

[56]  T. Bliss,et al.  Brain-Derived Neurotrophic Factor Induces Long-Term Potentiation in Intact Adult Hippocampus: Requirement for ERK Activation Coupled to CREB and Upregulation of Arc Synthesis , 2002, The Journal of Neuroscience.

[57]  E. Krebs,et al.  The mitogen-activated protein kinase activator. , 1992, Current opinion in cell biology.

[58]  A. F. Castro,et al.  A growing family of guanine nucleotide exchange factors is responsible for activation of Ras-family GTPases. , 2002, Progress in nucleic acid research and molecular biology.

[59]  M. McMahon,et al.  Copyright � 1996, American Society for Microbiology Raf, but Not MEK or ERK, Is Sufficient for Differentiation of , 1996 .

[60]  R. Huganir,et al.  The Role of Synaptic GTPase-Activating Protein in Neuronal Development and Synaptic Plasticity , 2003, The Journal of Neuroscience.

[61]  B. Balleine,et al.  Acquisition and Performance of Goal-Directed Instrumental Actions Depends on ERK Signaling in Distinct Regions of Dorsal Striatum in Rats , 2010, Journal of Neuroscience.

[62]  M. Sur,et al.  Major Vault Protein, a Candidate Gene in 16p11.2 Microdeletion Syndrome, Is Required for the Homeostatic Regulation of Visual Cortical Plasticity , 2018, The Journal of Neuroscience.

[63]  Robert J. Lefkowitz,et al.  Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[64]  X. F. Wang,et al.  MECP2 promotes cell proliferation by activating ERK1/2 and inhibiting p38 activity in human hepatocellular carcinoma HEPG2 cells. , 2013, Cellular and molecular biology.

[65]  Jodi Gureasko,et al.  Membrane-dependent signal integration by the Ras activator Son of sevenless , 2008, Nature Structural &Molecular Biology.

[66]  Hyejin Kang,et al.  Translational Control by MAPK Signaling in Long-Term Synaptic Plasticity and Memory , 2004, Cell.

[67]  M. Greenberg,et al.  Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of Ras , 1994, Neuron.

[68]  J. David Sweatt,et al.  The MAPK cascade is required for mammalian associative learning , 1998, Nature Neuroscience.

[69]  P. Williams,et al.  Brief Report: The Association of Neurofibromatosis Type 1 and Autism , 1998, Journal of autism and developmental disorders.

[70]  T. Sturgill,et al.  Rapid stimulation by insulin of a serine/threonine kinase in 3T3-L1 adipocytes that phosphorylates microtubule-associated protein 2 in vitro. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[71]  M. Bennett,et al.  Elevated ERK/p90 ribosomal S6 kinase activity underlies audiogenic seizure susceptibility in fragile X mice , 2016, Proceedings of the National Academy of Sciences.

[72]  S. Ozonoff,et al.  Cognitive impairment in neurofibromatosis type 1. , 1999, American journal of medical genetics.

[73]  Muffy Calder,et al.  The Mammalian MAPK/ERK Pathway Exhibits Properties of a Negative Feedback Amplifier , 2010, Science Signaling.

[74]  E. Kandel,et al.  Genetic Demonstration of a Role for PKA in the Late Phase of LTP and in Hippocampus-Based Long-Term Memory , 1997, Cell.

[75]  S. Bale,et al.  Molecular and functional analysis of a novel MEK2 mutation in cardio‐facio‐cutaneous syndrome: Transmission through four generations , 2010, American journal of medical genetics. Part A.

[76]  H. McFarlane,et al.  Autism‐like behavioral phenotypes in BTBR T+tf/J mice , 2008, Genes, brain, and behavior.

[77]  M E Greenberg,et al.  Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. , 1993, Science.

[78]  M. Camps,et al.  The nucleus, a site for signal termination by sequestration and inactivation of p42/p44 MAP kinases. , 2001, Journal of cell science.

[79]  E. Klann,et al.  Long-Term Depression in the Adult Hippocampus In Vivo Involves Activation of Extracellular Signal-Regulated Kinase and Phosphorylation of Elk-1 , 2002, The Journal of Neuroscience.

[80]  N. Alessi,et al.  Autistic disorder in Noonan syndrome. , 2008, Journal of intellectual disability research : JIDR.

[81]  Tony Pawson,et al.  Specificity in Signal Transduction From Phosphotyrosine-SH2 Domain Interactions to Complex Cellular Systems , 2004, Cell.

[82]  J. Girault,et al.  Addictive and non‐addictive drugs induce distinct and specific patterns of ERK activation in mouse brain , 2004, The European journal of neuroscience.

[83]  J. Parsons,et al.  Mitogen-Activated Protein Kinase Feedback Phosphorylation Regulates MEK1 Complex Formation and Activation during Cellular Adhesion , 2004, Molecular and Cellular Biology.

[84]  M. Herbert,et al.  Pathway Network Analyses for Autism Reveal Multisystem Involvement, Major Overlaps with Other Diseases and Convergence upon MAPK and Calcium Signaling , 2016, PloS one.

[85]  M. Castrén Cortical neurogenesis in fragile X syndrome. , 2016, Frontiers in bioscience.

[86]  R. Emsley,et al.  Autism spectrum disorder and other neurobehavioural comorbidities in rare disorders of the Ras/MAPK pathway , 2017, Developmental medicine and child neurology.

[87]  Emmanuel Roze,et al.  Role of the ERK/MSK1 signalling pathway in chromatin remodelling and brain responses to drugs of abuse , 2009, Journal of neurochemistry.

[88]  D. Morrison Mechanisms regulating Raf‐1 activity in signal transduction pathways , 1995, Molecular reproduction and development.

[89]  R. Jope,et al.  GSK3 Influences Social Preference and Anxiety-Related Behaviors during Social Interaction in a Mouse Model of Fragile X Syndrome and Autism , 2010, PloS one.

[90]  Y. Mechref,et al.  Social learning and amygdala disruptions in Nf1 mice are rescued by blocking p21-activated kinase , 2014, Nature Neuroscience.

[91]  E. Nishida,et al.  The MAP kinase cascade is essential for diverse signal transduction pathways. , 1993, Trends in biochemical sciences.

[92]  J. Lacaille,et al.  Mutations in SYNGAP1 Cause Intellectual Disability, Autism, and a Specific Form of Epilepsy by Inducing Haploinsufficiency , 2013, Human mutation.

[93]  D. Geschwind,et al.  Specific Functions for ERK/MAPK Signaling during PNS Development , 2011, Neuron.

[94]  S. J. Martin,et al.  SynGAP Regulates ERK/MAPK Signaling, Synaptic Plasticity, and Learning in the Complex with Postsynaptic Density 95 and NMDA Receptor , 2002, The Journal of Neuroscience.

[95]  I. Weiler,et al.  Early‐phase ERK activation as a biomarker for metabolic status in fragile X syndrome , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[96]  X. F. Zhang,et al.  Raf meets Ras: completing the framework of a signal transduction pathway. , 1994, Trends in biochemical sciences.

[97]  C. Bearden,et al.  Autism traits in the RASopathies , 2013, Journal of Medical Genetics.

[98]  M. Kawamura,et al.  Brain-derived Neurotrophic Factor Enhances Neuronal Translation by Activating Multiple Initiation Processes , 2001, The Journal of Biological Chemistry.

[99]  K. Brami-Cherrier,et al.  Glutamate induces histone H3 phosphorylation but not acetylation in striatal neurons: role of mitogen‐ and stress‐activated kinase‐1 , 2006, Journal of neurochemistry.

[100]  Oliver E. Sturm,et al.  Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway. , 2005, The Biochemical journal.

[101]  Pat Levitt,et al.  The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders. , 2009, The Journal of clinical investigation.

[102]  A. Sharrocks,et al.  Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter , 1992, Nature.

[103]  M. Castelo‐Branco,et al.  Brain and behaviour phenotyping of a mouse model of neurofibromatosis type‐1: an MRI/DTI study on social cognition , 2016, Genes, brain, and behavior.

[104]  Pavel A. Puzerey,et al.  Disrupted ERK Signaling during Cortical Development Leads to Abnormal Progenitor Proliferation, Neuronal and Network Excitability and Behavior, Modeling Human Neuro-Cardio-Facial-Cutaneous and Related Syndromes , 2012, The Journal of Neuroscience.

[105]  Valerie J. Bolivar,et al.  Assessing autism-like behavior in mice: Variations in social interactions among inbred strains , 2007, Behavioural Brain Research.

[106]  Qixuan Chen,et al.  16p11.2 deletion and duplication: Characterizing neurologic phenotypes in a large clinically ascertained cohort , 2016, American journal of medical genetics. Part A.

[107]  Christos G. Gkogkas,et al.  Pharmacogenetic Inhibition of eIF4E-Dependent Mmp9 mRNA Translation Reverses Fragile X Syndrome-like Phenotypes , 2014, Cell reports.

[108]  J. Dougherty,et al.  Characterization of early communicative behavior in mouse models of neurofibromatosis type 1 , 2018, Autism research : official journal of the International Society for Autism Research.

[109]  J. Opitz,et al.  Noonan syndrome: a review. , 1985, American journal of medical genetics.

[110]  D. Linden,et al.  Activation of Presynaptic cAMP-Dependent Protein Kinase Is Required for Induction of Cerebellar Long-Term Potentiation , 1999, The Journal of Neuroscience.

[111]  Claudius F. Kratochwil,et al.  Aberrant differentiation of glutamatergic cells in neocortex of mouse model for fragile X syndrome , 2009, Neurobiology of Disease.

[112]  M. Segal,et al.  Protein kinase C and ERK involvement in dendritic spine plasticity in cultured rodent hippocampal neurons , 2003, The European journal of neuroscience.

[113]  R. Lefkowitz,et al.  Stable Interaction between β-Arrestin 2 and Angiotensin Type 1A Receptor Is Required for β-Arrestin 2-mediated Activation of Extracellular Signal-regulated Kinases 1 and 2* , 2004, Journal of Biological Chemistry.

[114]  E. Goldsmith,et al.  How MAP Kinases Are Regulated (*) , 1995, The Journal of Biological Chemistry.

[115]  M. Bear,et al.  Homosynaptic long-term depression in area CA1 of hippocampus and effects of N-methyl-D-aspartate receptor blockade. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[116]  J. Girault,et al.  Parsing Molecular and Behavioral Effects of Cocaine in Mitogen- and Stress-Activated Protein Kinase-1-Deficient Mice , 2005, The Journal of Neuroscience.

[117]  A. Ishii,et al.  ERK1/ERK2 MAPK Signaling is Required to Increase Myelin Thickness Independent of Oligodendrocyte Differentiation and Initiation of Myelination , 2012, The Journal of Neuroscience.

[118]  H. Wiley,et al.  Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking. , 2001, Molecular biology of the cell.

[119]  R. Malenka,et al.  Behavioral abnormalities and circuit defects in the basal ganglia of a mouse model of 16p11.2 deletion syndrome. , 2014, Cell reports.

[120]  R. Yasuda,et al.  AMPA receptors are exocytosed in stimulated spines and adjacent dendrites in a Ras-ERK–dependent manner during long-term potentiation , 2010, Proceedings of the National Academy of Sciences.

[121]  Jerry L. Adams,et al.  A protein kinase involved in the regulation of inflammatory cytokine biosynthesis , 1994, Nature.

[122]  J. Gutkind Regulation of Mitogen-Activated Protein Kinase Signaling Networks by G Protein-Coupled Receptors , 2000, Science's STKE.

[123]  Joseph E LeDoux,et al.  Activation of extracellular signal‐regulated kinase– mitogen‐activated protein kinase cascade in the amygdala is required for memory reconsolidation of auditory fear conditioning , 2005, The European journal of neuroscience.

[124]  R. Huganir,et al.  SynGAP regulates synaptic strength and mitogen-activated protein kinases in cultured neurons. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[125]  Christof Niehrs,et al.  Fibroblast growth factor signaling during early vertebrate development. , 2005, Endocrine reviews.

[126]  D. Morrison,et al.  KSR: a MAPK scaffold of the Ras pathway? , 2001, Journal of cell science.

[127]  L. Hunyady,et al.  Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[128]  R. Mark Henkelman,et al.  Neuroanatomical analysis of the BTBR mouse model of autism using magnetic resonance imaging and diffusion tensor imaging , 2013, NeuroImage.

[129]  E. Thiels,et al.  Stimulus-specific and differential distribution of activated extracellular signal-regulated kinase in the nucleus accumbens core and shell during Pavlovian-instrumental transfer , 2012, Brain Structure and Function.

[130]  G. Rumbaugh,et al.  Syngap1 Haploinsufficiency Damages a Postnatal Critical Period of Pyramidal Cell Structural Maturation Linked to Cortical Circuit Assembly , 2015, Biological Psychiatry.

[131]  Joseph E LeDoux,et al.  Molecular Mechanisms of Fear Learning and Memory , 2011, Cell.

[132]  M. Bear,et al.  Fragile X mental retardation protein and synaptic plasticity , 2013, Molecular Brain.

[133]  Kun-Liang Guan,et al.  Mechanisms of regulating the Raf kinase family. , 2003, Cellular signalling.

[134]  X. Chen,et al.  Hippocampal CRE-mediated gene expression is required for contextual memory formation , 2002, Nature Neuroscience.

[135]  G. M. Di Guglielmo,et al.  Compartmentalization of SHC, GRB2 and mSOS, and hyperphosphorylation of Raf‐1 by EGF but not insulin in liver parenchyma. , 1994, The EMBO journal.

[136]  Stephen T Warren,et al.  Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors , 2007, Proceedings of the National Academy of Sciences.

[137]  R. Mullins,et al.  β-Arrestin–Dependent Endocytosis of Proteinase-Activated Receptor 2 Is Required for Intracellular Targeting of Activated Erk1/2 , 2000, The Journal of cell biology.

[138]  M. Caron,et al.  The Stability of the G Protein-coupled Receptor-β-Arrestin Interaction Determines the Mechanism and Functional Consequence of ERK Activation* , 2003, The Journal of Biological Chemistry.

[139]  H. Yao,et al.  cAMP Activates MAP Kinase and Elk-1 through a B-Raf- and Rap1-Dependent Pathway , 1997, Cell.

[140]  E. I. Pierpont,et al.  Learning and memory in children with Noonan syndrome , 2013, American journal of medical genetics. Part A.

[141]  R. Malinow,et al.  Ras and Rap Control AMPA Receptor Trafficking during Synaptic Plasticity , 2002, Cell.

[142]  R. Lefkowitz,et al.  β-Arrestin Scaffolding of the ERK Cascade Enhances Cytosolic ERK Activity but Inhibits ERK-mediated Transcription following Angiotensin AT1a Receptor Stimulation* , 2002, The Journal of Biological Chemistry.

[143]  Evan T. Geller,et al.  Patterns and rates of exonic de novo mutations in autism spectrum disorders , 2012, Nature.

[144]  H. Yoon,et al.  Tuberous sclerosis-2 tumor suppressor modulates ERK and B-Raf activity in transformed renal epithelial cells. , 2004, American journal of physiology. Renal physiology.

[145]  Joseph Schlessinger,et al.  SH2 and PTB Domains in Tyrosine Kinase Signaling , 2003, Science's STKE.

[146]  Ming Zhou,et al.  Regulation of Raf-1 by direct feedback phosphorylation. , 2005, Molecular cell.

[147]  Y. Shaham,et al.  Role of ERK in cocaine addiction , 2006, Trends in Neurosciences.

[148]  P. Dash,et al.  A Mitogen-Activated Protein Kinase Cascade in the CA1/CA2 Subfield of the Dorsal Hippocampus Is Essential for Long-Term Spatial Memory , 1999, The Journal of Neuroscience.

[149]  F. Castellanos,et al.  Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1 , 2013, Developmental medicine and child neurology.

[150]  E. Nishida,et al.  Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway , 2002, Nature Cell Biology.

[151]  C. Ottmann,et al.  Synergistic binding of the phosphorylated S233- and S259-binding sites of C-RAF to one 14-3-3ζ dimer. , 2012, Journal of molecular biology.

[152]  D. Riethmacher,et al.  Neurofibromin Modulates Adult Hippocampal Neurogenesis and Behavioral Effects of Antidepressants , 2012, The Journal of Neuroscience.

[153]  S. Grant,et al.  A role for the Ras signalling pathway in synaptic transmission and long-term memory , 1997, Nature.

[154]  M. Avoli,et al.  Decrease of SYNGAP1 in GABAergic cells impairs inhibitory synapse connectivity, synaptic inhibition and cognitive function , 2016, Nature Communications.

[155]  Michael E. Greenberg,et al.  Activity-dependent neuronal signalling and autism spectrum disorder , 2013, Nature.

[156]  C. Bagni,et al.  Learning and behavioral deficits associated with the absence of the fragile X mental retardation protein: what a fly and mouse model can teach us , 2014, Learning & memory.

[157]  G. Lynch,et al.  Reduced Cognition in Syngap1 Mutants Is Caused by Isolated Damage within Developing Forebrain Excitatory Neurons , 2014, Neuron.

[158]  M. Giustetto,et al.  Role of ERK signaling in activity-dependent modifications of histone proteins , 2014, Neuropharmacology.

[159]  J. Schlessinger,et al.  Signal transduction by allosteric receptor oligomerization. , 1988, Trends in biochemical sciences.

[160]  P. Carlen,et al.  Reduced Cortical Synaptic Plasticity and GluR1 Expression Associated with Fragile X Mental Retardation Protein Deficiency , 2002, Molecular and Cellular Neuroscience.

[161]  Joseph E LeDoux,et al.  Memory consolidation for contextual and auditory fear conditioning is dependent on protein synthesis, PKA, and MAP kinase. , 1999, Learning & memory.

[162]  D. Storm,et al.  Making New Connections Role of ERK/MAP Kinase Signaling in Neuronal Plasticity , 1999, Neuron.

[163]  D. Morrison,et al.  C-TAK1 regulates Ras signaling by phosphorylating the MAPK scaffold, KSR1. , 2001, Molecular cell.

[164]  R. Emsley,et al.  Neurofibromatosis Type 1 and Autism Spectrum Disorder , 2013, Pediatrics.

[165]  Alcino J. Silva,et al.  Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1 , 2002, Nature.

[166]  G. R. Seabrook,et al.  The group I mGlu receptor agonist DHPG induces a novel form of LTD in the CA1 region of the hippocampus , 1997, Neuropharmacology.

[167]  Y. Miyamoto,et al.  Cellular signaling of Dock family proteins in neural function. , 2010, Cellular signalling.

[168]  J. Hancock,et al.  Ras trafficking, localization and compartmentalized signalling. , 2012, Seminars in cell & developmental biology.

[169]  Chih-Chieh Wang,et al.  SynGAP Regulates Protein Synthesis and Homeostatic Synaptic Plasticity in Developing Cortical Networks , 2013, PloS one.

[170]  D. Barford,et al.  Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization. , 2005, Molecular cell.

[171]  L. Cantley,et al.  Phosphorylation-dependent paxillin-ERK association mediates hepatocyte growth factor-stimulated epithelial morphogenesis. , 2003, Molecular cell.

[172]  S. Dudek,et al.  Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Activation in Somatodendritic Compartments: Roles of Action Potentials, Frequency, and Mode of Calcium Entry , 2001, The Journal of Neuroscience.

[173]  Nobumasa Kato,et al.  Association between the neurofibromatosis‐1 (NF1) locus and autism in the Japanese population , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[174]  P. Pandolfi,et al.  Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer. , 2007, Cancer research.

[175]  D. Sacks,et al.  IQGAP1 Is a Scaffold for Mitogen-Activated Protein Kinase Signaling , 2005, Molecular and Cellular Biology.

[176]  J. Medina,et al.  ERK1/2 activation is necessary for BDNF to increase dendritic spine density in hippocampal CA1 pyramidal neurons. , 2004, Learning & memory.

[177]  E. Gilles,et al.  Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors , 2002, Nature Biotechnology.

[178]  Jill L Silverman,et al.  Repetitive Self-Grooming Behavior in the BTBR Mouse Model of Autism is Blocked by the mGluR5 Antagonist MPEP , 2010, Neuropsychopharmacology.

[179]  S. Mcconnell,et al.  FGF signalling generates ventral telencephalic cells independently of SHH , 2006, Development.

[180]  J. Sweatt,et al.  Deletion of ERK2 Mitogen-Activated Protein Kinase Identifies Its Key Roles in Cortical Neurogenesis and Cognitive Function , 2008, The Journal of Neuroscience.

[181]  D. C. Blanchard,et al.  The BTBR mouse model of idiopathic autism – Current view on mechanisms , 2017, Neuroscience & Biobehavioral Reviews.

[182]  S. Grant,et al.  A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability , 2007, Nature Neuroscience.

[183]  M. Cobb,et al.  Evidence for a Ras-dependent extracellular signal-regulated protein kinase (ERK) cascade. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[184]  E R Kandel,et al.  Capture of a protein synthesis-dependent component of long-term depression. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[185]  R. Lefkowitz,et al.  Differential Kinetic and Spatial Patterns of β-Arrestin and G Protein-mediated ERK Activation by the Angiotensin II Receptor* , 2004, Journal of Biological Chemistry.

[186]  D. Pinto,et al.  Structural variation of chromosomes in autism spectrum disorder. , 2008, American journal of human genetics.

[187]  Alcino J. Silva,et al.  The HMG-CoA Reductase Inhibitor Lovastatin Reverses the Learning and Attention Deficits in a Mouse Model of Neurofibromatosis Type 1 , 2005, Current Biology.

[188]  Ning Cheng,et al.  Dendritic overgrowth and elevated ERK signaling during neonatal development in a mouse model of autism , 2017, PloS one.

[189]  Alcino J. Silva,et al.  Neurofibromin Regulation of ERK Signaling Modulates GABA Release and Learning , 2008, Cell.

[190]  N. Sonenberg,et al.  Novel Translational Control in Arc-dependent Long Term Potentiation Consolidation in Vivo* , 2009, The Journal of Biological Chemistry.

[191]  C. Bearden,et al.  Reverse Pathway Genetic Approach Identifies Epistasis in Autism Spectrum Disorders , 2017, PLoS genetics.

[192]  David P Wolfer,et al.  Knockout of ERK1 MAP Kinase Enhances Synaptic Plasticity in the Striatum and Facilitates Striatal-Mediated Learning and Memory , 2002, Neuron.

[193]  Michael F. Walker,et al.  De novo mutations revealed by whole-exome sequencing are strongly associated with autism , 2012, Nature.

[194]  R. Huganir,et al.  MAPK cascade signalling and synaptic plasticity , 2004, Nature Reviews Neuroscience.

[195]  Jiahuai Han,et al.  Pro-inflammatory Cytokines and Environmental Stress Cause p38 Mitogen-activated Protein Kinase Activation by Dual Phosphorylation on Tyrosine and Threonine (*) , 1995, The Journal of Biological Chemistry.

[196]  A. Brunet,et al.  B-Raf protein isoforms interact with and phosphorylate Mek-1 on serine residues 218 and 222. , 1995, Oncogene.

[197]  Mark F. Bear,et al.  Altered synaptic plasticity in a mouse model of fragile X mental retardation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[198]  Robert H Miller,et al.  Signaling through ERK1/2 Controls Myelin Thickness during Myelin Repair in the Adult Central Nervous System , 2013, The Journal of Neuroscience.

[199]  M. Krug,et al.  Anisomycin blocks the late phase of long-term potentiation in the dentate gyrus of freely moving rats , 1984, Brain Research Bulletin.

[200]  Eric Klann,et al.  ERK and mTOR Signaling Couple β-Adrenergic Receptors to Translation Initiation Machinery to Gate Induction of Protein Synthesis-dependent Long-term Potentiation* , 2007, Journal of Biological Chemistry.

[201]  Y. Dudai,et al.  Specific and Differential Activation of Mitogen-Activated Protein Kinase Cascades by Unfamiliar Taste in the Insular Cortex of the Behaving Rat , 1998, The Journal of Neuroscience.

[202]  M. Bear,et al.  Hypersensitivity to mGluR5 and ERK1/2 Leads to Excessive Protein Synthesis in the Hippocampus of a Mouse Model of Fragile X Syndrome , 2010, The Journal of Neuroscience.

[203]  S. Kanner,et al.  A 42-kD tyrosine kinase substrate linked to chromaffin cell secretion exhibits an associated MAP kinase activity and is highly related to a 42-kD mitogen-stimulated protein in fibroblasts , 1990, The Journal of cell biology.

[204]  R. Brambilla,et al.  Lentiviral vectors to study the differential function of ERK1 and ERK2 MAP kinases. , 2010, Methods in molecular biology.

[205]  W. Mobley,et al.  Nerve Growth Factor Activates Persistent Rap1 Signaling in Endosomes , 2001, The Journal of Neuroscience.

[206]  Alcino J. Silva,et al.  Forebrain‐specific knockout of B‐raf kinase leads to deficits in hippocampal long‐term potentiation, learning, and memory , 2006, Journal of neuroscience research.

[207]  J. Blenis,et al.  Nuclear localization and regulation of erk- and rsk-encoded protein kinases , 1992, Molecular and cellular biology.

[208]  L. Feig,et al.  Regulation of Neuronal Function by Ras-GRF Exchange Factors. , 2011, Genes & cancer.

[209]  T. Sturgill,et al.  Insulin-stimulated microtubule-associated protein kinase is phosphorylated on tyrosine and threonine in vivo. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[210]  April E Hebert,et al.  Extracellular signal-regulated kinase activity in the entorhinal cortex is necessary for long-term spatial memory. , 2002, Learning & memory.

[211]  M. White,et al.  Uncoupling Raf1 from MEK1/2 Impairs Only a Subset of Cellular Responses to Raf Activation* , 2000, The Journal of Biological Chemistry.

[212]  L. Maffei,et al.  Developmental Downregulation of Histone Posttranslational Modifications Regulates Visual Cortical Plasticity , 2007, Neuron.

[213]  Stephen J. Guter,et al.  Convergence of Genes and Cellular Pathways Dysregulated in Autism Spectrum Disorders , 2014, American journal of human genetics.

[214]  J. Sweatt,et al.  ERK/MAPK regulates hippocampal histone phosphorylation following contextual fear conditioning. , 2006, Learning & memory.

[215]  Joshua M. Korn,et al.  Association between microdeletion and microduplication at 16p11.2 and autism. , 2008, The New England journal of medicine.

[216]  E. Nishida,et al.  Regulatory mechanisms and function of ERK MAP kinases. , 2004, Journal of biochemistry.

[217]  D. Morrison,et al.  Integrating signals from RTKs to ERK/MAPK , 2007, Oncogene.

[218]  K. Guan,et al.  Regulation of Raf through Phosphorylation and N Terminus-C Terminus Interaction* , 2003, Journal of Biological Chemistry.

[219]  E. Nishida,et al.  Evidence for Existence of a Nuclear Pore Complex-mediated, Cytosol-independent Pathway of Nuclear Translocation of ERK MAP Kinase in Permeabilized Cells* , 2001, The Journal of Biological Chemistry.

[220]  Z. Goldsmith,et al.  G Protein regulation of MAPK networks , 2007, Oncogene.

[221]  J. Sweatt,et al.  The Mitogen-Activated Protein Kinase Cascade Couples PKA and PKC to cAMP Response Element Binding Protein Phosphorylation in Area CA1 of Hippocampus , 1999, The Journal of Neuroscience.

[222]  A. Wittinghofer,et al.  Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1. , 1998, Human molecular genetics.

[223]  Stephan J Sanders,et al.  A framework for the interpretation of de novo mutation in human disease , 2014, Nature Genetics.

[224]  R. Morris,et al.  MSK1 Regulates Homeostatic and Experience-Dependent Synaptic Plasticity , 2012, The Journal of Neuroscience.

[225]  W. Kolch,et al.  Regulation and Role of Raf-1/B-Raf Heterodimerization , 2006, Molecular and Cellular Biology.

[226]  S. Davis,et al.  The MAPK/ERK Cascade Targets Both Elk-1 and cAMP Response Element-Binding Protein to Control Long-Term Potentiation-Dependent Gene Expression in the Dentate Gyrus In Vivo , 2000, The Journal of Neuroscience.

[227]  Ming-Ming Zhou,et al.  Structure and regulation of MAPK phosphatases. , 2004, Cellular signalling.

[228]  K. Luby-Phelps,et al.  ERK2 enters the nucleus by a carrier-independent mechanism , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[229]  Long-Sheng Chang,et al.  ERK Inhibition Rescues Defects in Fate Specification of Nf1-Deficient Neural Progenitors and Brain Abnormalities , 2012, Cell.

[230]  T. Iidaka,et al.  Resequencing and Association Analysis of Six PSD-95-Related Genes as Possible Susceptibility Genes for Schizophrenia and Autism Spectrum Disorders , 2016, Scientific Reports.

[231]  C. Betancur,et al.  Etiological heterogeneity in autism spectrum disorders: More than 100 genetic and genomic disorders and still counting , 2011, Brain Research.

[232]  V. Caviness,et al.  Proliferative events in the cerebral ventricular zone , 1995, Brain and Development.

[233]  E. Nishida,et al.  Microtubule-associated-protein (MAP) kinase activated by nerve growth factor and epidermal growth factor in PC12 cells. Identity with the mitogen-activated MAP kinase of fibroblastic cells. , 1990, European journal of biochemistry.

[234]  D. Conrad,et al.  Recurrent 16p11.2 microdeletions in autism. , 2007, Human molecular genetics.

[235]  Karl Deisseroth,et al.  Spaced stimuli stabilize MAPK pathway activation and its effects on dendritic morphology , 2001, Nature Neuroscience.

[236]  Joseph E LeDoux,et al.  Activation of ERK/MAP Kinase in the Amygdala Is Required for Memory Consolidation of Pavlovian Fear Conditioning , 2000, The Journal of Neuroscience.

[237]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[238]  P. Cohen,et al.  Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. , 1992, The Biochemical journal.

[239]  K. Rauen,et al.  The RASopathies: Syndromes of Ras/MAPK Pathway Dysregulation , 2012 .

[240]  G. Collingridge,et al.  Excitatory amino acids in synaptic transmission in the Schaffer collateral‐commissural pathway of the rat hippocampus. , 1983, The Journal of physiology.

[241]  R. Marais,et al.  Kinase-activating and kinase-impaired cardio-facio-cutaneous syndrome alleles have activity during zebrafish development and are sensitive to small molecule inhibitors , 2009, Human molecular genetics.

[242]  Daniel Johnston,et al.  Deletion of Kv4.2 Gene Eliminates Dendritic A-Type K+ Current and Enhances Induction of Long-Term Potentiation in Hippocampal CA1 Pyramidal Neurons , 2006, The Journal of Neuroscience.

[243]  Walter Kolch,et al.  Protein kinase Cα activates RAF-1 by direct phosphorylation , 1993, Nature.

[244]  D. Ginty,et al.  Mouse and human phenotypes indicate a critical conserved role for ERK2 signaling in neural crest development , 2008, Proceedings of the National Academy of Sciences.

[245]  J. Crawley,et al.  Behavioral and Neuroanatomical Phenotypes in Mouse Models of Autism , 2015, Neurotherapeutics.

[246]  A. Ashworth,et al.  Identification of the sites in MAP kinase kinase‐1 phosphorylated by p74raf‐1. , 1994, The EMBO journal.

[247]  G. Rumbaugh,et al.  Species-conserved SYNGAP1 phenotypes associated with neurodevelopmental disorders , 2018, Molecular and Cellular Neuroscience.

[248]  M. Castrén,et al.  Tissue Plasminogen Activator Contributes to Alterations of Neuronal Migration and Activity-Dependent Responses in Fragile X Mice , 2014, The Journal of Neuroscience.

[249]  A. Eychène,et al.  The Mouse B-raf Gene Encodes Multiple Protein Isoforms with Tissue-specific Expression (*) , 1995, The Journal of Biological Chemistry.

[250]  S. Fasano,et al.  Ras–ERK Signaling in Behavior: Old Questions and New Perspectives , 2011, Front. Behav. Neurosci..

[251]  C. Der,et al.  Guanine nucleotide exchange factors: Activators of Ras superfamily proteins , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[252]  S. Haggarty,et al.  MeCP2-regulated miRNAs control early human neurogenesis through differential effects on ERK and AKT signaling , 2017, Molecular Psychiatry.

[253]  C. Heldin,et al.  Ligand-induced dimerization of growth factor receptors: variations on the theme. , 1996, Cytokine & growth factor reviews.

[254]  Xinglong Wang,et al.  Activation of the extracellular signal‐regulated kinase pathway contributes to the behavioral deficit of fragile x‐syndrome , 2012, Journal of neurochemistry.

[255]  J. David Sweatt,et al.  Activation of p42 Mitogen-activated Protein Kinase in Hippocampal Long Term Potentiation* , 1996, The Journal of Biological Chemistry.

[256]  P. Stork,et al.  PKA phosphorylation of Src mediates Rap1 activation in NGF and cAMP signaling in PC12 cells , 2004, Journal of Cell Science.

[257]  R. Roskoski,et al.  RAF protein-serine/threonine kinases: structure and regulation. , 2010, Biochemical and biophysical research communications.

[258]  Jonathan A. Cooper,et al.  Purification and characterization of mitogen-activated protein kinase activator(s) from epidermal growth factor-stimulated A431 cells. , 1992, The Journal of biological chemistry.

[259]  Susumu Tonegawa,et al.  Translational Regulatory Mechanisms in Persistent Forms of Synaptic Plasticity , 2004, Neuron.

[260]  U. Frey,et al.  Anisomycin, an inhibitor of protein synthesis, blocks late phases of LTP phenomena in the hippocampal CA1 region in vitro , 1988, Brain Research.

[261]  M. Götz,et al.  Developmental cell biology: The cell biology of neurogenesis , 2005, Nature Reviews Molecular Cell Biology.

[262]  J. Dubé,et al.  Lovastatin corrects ERK pathway hyperactivation in fragile X syndrome: potential of platelet’s signaling cascades as new outcome measures in clinical trials , 2016, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[263]  Richard Marais,et al.  The RAF proteins take centre stage , 2004, Nature Reviews Molecular Cell Biology.

[264]  A. Blaukat,et al.  Protein tyrosine kinase-mediated pathways in G protein-coupled receptor signaling , 2007, Cell Biochemistry and Biophysics.

[265]  J. B. Sajous,et al.  Ras signalling on the endoplasmic reticulum and the Golgi , 2002, Nature Cell Biology.

[266]  L. Richards,et al.  Mapk/Erk activation in an animal model of social deficits shows a possible link to autism , 2014, Molecular Autism.

[267]  H. Schaeffer,et al.  MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. , 1998, Science.

[268]  M. Kohno,et al.  ERK pathway positively regulates the expression of Sprouty genes. , 2001, Biochemical and biophysical research communications.

[269]  Henry Kennedy,et al.  Cell-cycle control and cortical development , 2007, Nature Reviews Neuroscience.

[270]  P. Howlin,et al.  Autism spectrum disorders in genetic syndromes: implications for diagnosis, intervention and understanding the wider autism spectrum disorder population. , 2009, Journal of intellectual disability research : JIDR.

[271]  M. Fürthauer,et al.  Sef is a feedback-induced antagonist of Ras/MAPK-mediated FGF signalling , 2002, Nature Cell Biology.

[272]  T. Ogura,et al.  New BRAF knockin mice provide a pathogenetic mechanism of developmental defects and a therapeutic approach in cardio-facio-cutaneous syndrome. , 2014, Human molecular genetics.

[273]  M. Giustetto,et al.  Morphine withdrawal produces ERK-dependent and ERK-independent epigenetic marks in neurons of the nucleus accumbens and lateral septum , 2013, Neuropharmacology.

[274]  Walter Kolch,et al.  Identification of the Mechanisms Regulating the Differential Activation of the MAPK Cascade by Epidermal Growth Factor and Nerve Growth Factor in PC12 Cells* , 2001, The Journal of Biological Chemistry.

[275]  Ashwin Woodhoo,et al.  A Central Role for the ERK-Signaling Pathway in Controlling Schwann Cell Plasticity and Peripheral Nerve Regeneration In Vivo , 2012, Neuron.

[276]  G. Landreth,et al.  The ERK2 Mitogen-Activated Protein Kinase Regulates the Timing of Oligodendrocyte Differentiation , 2011, The Journal of Neuroscience.

[277]  C. Allis,et al.  Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. , 2000, Molecular cell.

[278]  M E Greenberg,et al.  Calcium signaling in neurons: molecular mechanisms and cellular consequences. , 1995, Science.

[279]  E. Klann,et al.  Genetic Removal of p70 S6 Kinase 1 Corrects Molecular, Synaptic, and Behavioral Phenotypes in Fragile X Syndrome Mice , 2012, Neuron.

[280]  Xuejun Jiang,et al.  Coordinated traffic of Grb2 and Ras during epidermal growth factor receptor endocytosis visualized in living cells. , 2002, Molecular biology of the cell.

[281]  G. Landreth,et al.  Pharmacological Inhibition of ERK Signaling Rescues Pathophysiology and Behavioral Phenotype Associated with 16p11.2 Chromosomal Deletion in Mice , 2018, The Journal of Neuroscience.

[282]  Gavin Rumbaugh,et al.  Pathogenic SYNGAP1 Mutations Impair Cognitive Development by Disrupting Maturation of Dendritic Spine Synapses , 2012, Cell.

[283]  E. Klann,et al.  Biochemical mechanisms for translational regulation in synaptic plasticity , 2004, Nature Reviews Neuroscience.

[284]  G. M. Di Guglielmo,et al.  Compartmentalized signal transduction by receptor tyrosine kinases. , 1995, Trends in cell biology.

[285]  Paul W. Frankland,et al.  A mouse model for the learning and memory deficits associated with neurofibromatosis type I , 1997, Nature Genetics.

[286]  Joseph Vithayathil,et al.  The 16p11.2 Deletion Mouse Model of Autism Exhibits Altered Cortical Progenitor Proliferation and Brain Cytoarchitecture Linked to the ERK MAPK Pathway , 2015, The Journal of Neuroscience.

[287]  Jacqueline N. Crawley,et al.  Mouse behavioral tasks relevant to autism: Phenotypes of 10 inbred strains , 2007, Behavioural Brain Research.

[288]  Gary Lynch,et al.  Long-Term Memory Deficits are Associated with Elevated Synaptic ERK1/2 Activation and Reversed by mGluR5 Antagonism in an Animal Model of Autism , 2014, Neuropsychopharmacology.

[289]  A. Ornoy,et al.  Genetic Syndromes, Maternal Diseases and Antenatal Factors Associated with Autism Spectrum Disorders (ASD) , 2016, Front. Neurosci..

[290]  D. B. Bell,et al.  Low stress reactivity and neuroendocrine factors in the BTBR T+tf/J mouse model of autism , 2010, Neuroscience.

[291]  Michel Cyr,et al.  Intrastriatal inhibition of extracellular signal-regulated kinases impaired the consolidation phase of motor skill learning , 2010, Neurobiology of Learning and Memory.

[292]  J. Bossert,et al.  Cocaine‐induced CREB phosphorylation in nucleus accumbens of cocaine‐sensitized rats is enabled by enhanced activation of extracellular signal‐related kinase, but not protein kinase A , 2005, Journal of neurochemistry.

[293]  Ha-won Jeong,et al.  IQGAP1 Binds Rap1 and Modulates Its Activity* , 2004, Journal of Biological Chemistry.

[294]  E. Mercuri,et al.  Behavioral Profile in RASopathies , 2014, American journal of medical genetics. Part A.

[295]  J. Shendure,et al.  A de novo convergence of autism genetics and molecular neuroscience , 2014, Trends in Neurosciences.

[296]  J. Blenis,et al.  ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions , 2004, Microbiology and Molecular Biology Reviews.

[297]  R. Lefkowitz,et al.  β-Arrestin-mediated receptor trafficking and signal transduction. , 2011, Trends in pharmacological sciences.

[298]  J. Qin,et al.  Identification of Raf-1 S471 as a novel phosphorylation site critical for Raf-1 and B-Raf kinase activities and for MEK binding. , 2005, Molecular biology of the cell.

[299]  E. Zackai,et al.  Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: Cast a wide FISHing net! , 2001, Genetics in Medicine.

[300]  David L. Brautigan,et al.  Raf-1 activates MAP kinase-kinase , 1992, Nature.

[301]  G L Johnson,et al.  Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. , 1994, Science.

[302]  C. Anastasaki,et al.  Continual low-level MEK inhibition ameliorates cardio-facio-cutaneous phenotypes in zebrafish , 2012, Disease Models & Mechanisms.

[303]  M. Bear,et al.  Extracellular Signal-Regulated Protein Kinase Activation Is Required for Metabotropic Glutamate Receptor-Dependent Long-Term Depression in Hippocampal Area CA1 , 2004, The Journal of Neuroscience.

[304]  R. Emsley,et al.  Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population‐based study , 2013, Developmental medicine and child neurology.

[305]  E. Wiemer,et al.  The Major Vault Protein Is a Novel Substrate for the Tyrosine Phosphatase SHP-2 and Scaffold Protein in Epidermal Growth Factor Signaling* , 2004, Journal of Biological Chemistry.

[306]  G. Johnson,et al.  Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases , 2002, Science.

[307]  Yasushi Kobayashi,et al.  Transient Blockade of ERK Phosphorylation in the Critical Period Causes Autistic Phenotypes as an Adult in Mice , 2015, Scientific Reports.

[308]  E. Formstecher,et al.  PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. , 2001, Developmental cell.

[309]  J. Woodgett,et al.  The stress-activated protein kinase subfamily of c-Jun kinases , 1994, Nature.

[310]  James R. Woodgett,et al.  Phosphorylation of c-jun mediated by MAP kinases , 1991, Nature.

[311]  Kun-Liang Guan,et al.  Isolation and Characterization of a Novel Dual Specific Phosphatase, HVH2, Which Selectively Dephosphorylates the Mitogen-activated Protein Kinase (*) , 1995, The Journal of Biological Chemistry.

[312]  J. David Sweatt,et al.  A Requirement for the Mitogen-activated Protein Kinase Cascade in Hippocampal Long Term Potentiation* , 1997, The Journal of Biological Chemistry.

[313]  A. Kriegstein,et al.  The role of intermediate progenitor cells in the evolutionary expansion of the cerebral cortex. , 2006, Cerebral cortex.

[314]  J. Downward,et al.  Control of ras activation. , 1996, Cancer surveys.

[315]  David A. Williams,et al.  Hyperactivation of P21ras and the Hematopoietic-Specific Rho Gtpase, Rac2, Cooperate to Alter the Proliferation of Neurofibromin-Deficient Mast Cells in Vivo and in Vitro , 2001, The Journal of experimental medicine.

[316]  D. Friel,et al.  Chronic impairment of ERK signaling in glutamatergic neurons of the forebrain does not affect spatial memory retention and LTP in the same manner as acute blockade of the ERK pathway , 2017, Hippocampus.

[317]  H. Kawasaki,et al.  Requirement for Mitogen-activated Protein Kinase in Cerebellar Long Term Depression* , 1999, The Journal of Biological Chemistry.

[318]  C. Der,et al.  Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer , 2007, Oncogene.

[319]  I. Weiler,et al.  Aberrant early-phase ERK inactivation impedes neuronal function in fragile X syndrome , 2008, Proceedings of the National Academy of Sciences.

[320]  J. Caboche,et al.  Recall and Reconsolidation of Contextual Fear Memory: Differential Control by ERK and Zif268 Expression Dosage , 2013, PloS one.

[321]  H. Horvitz,et al.  The ksr-1 gene encodes a novel protein kinase involved in Ras-mediated signaling in C. elegans , 1995, Cell.

[322]  J. Cleveland,et al.  Expression of raf family proto-oncogenes in normal mouse tissues. , 1990, Oncogene.

[323]  T. Bliss,et al.  Low‐frequency trains of paired stimuli induce long‐term depression in area CA1 but not in dentate gyrus of the intact rat , 1996, Hippocampus.

[324]  M. Cobb,et al.  The mitogen-activated protein kinases, ERK1 and ERK2. , 1994, Seminars in cancer biology.

[325]  Alcino J. Silva,et al.  Mechanism and treatment for the learning and memory deficits associated with mouse models of Noonan syndrome , 2014, Nature Neuroscience.

[326]  J. David Sweatt,et al.  Epigenetic Mechanisms in Cognition , 2011, Neuron.

[327]  J. Lacaille,et al.  De Novo SYNGAP1 Mutations in Nonsyndromic Intellectual Disability and Autism , 2011, Biological Psychiatry.

[328]  Paul Tempst,et al.  Phosphorylation and Functional Inactivation of TSC2 by Erk Implications for Tuberous Sclerosisand Cancer Pathogenesis , 2005, Cell.

[329]  M. Barbacid,et al.  Constitutive activation of B-Raf in the mouse germ line provides a model for human cardio-facio-cutaneous syndrome , 2011, Proceedings of the National Academy of Sciences.

[330]  T. Pawson Getting down to specifics , 1995, Nature.

[331]  E. Mccleskey,et al.  Rap1 mediates sustained MAP kinase activation induced by nerve growth factor , 1998, Nature.

[332]  Alcino J. Silva,et al.  MAPK, CREB and zif268 are all required for the consolidation of recognition memory. , 2003, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[333]  D. Morrison,et al.  Identification of the major phosphorylation sites of the Raf-1 kinase. , 1993, The Journal of biological chemistry.